Lumos Labs, announced today that the FDA has granted 510(k) clearance for LumosityRx, a prescription digital therapeutic for adults with ADHD.

In some parts of the world, record numbers of people are being diagnosed with attention deficit hyperactivity disorder (ADHD) ...

Lumos Labs has gained US Food and Drug Administration (FDA) clearance for LumosityRx, a prescription digital therapeutic (PDT) that aims to improve attention span in adult patients with attention ...

A study of 8,300+ children found even modest social media use gradually increased ADHD-like inattention, while TV and video ...

LumosityRx is a prescription therapeutic app that includes 13 cognitive training games targeting key brain processes connected to attention function.

Adults with autism spectrum disorder (ASD) and other neurodevelopmental disorders (NDDs) often lose access to specialized ...

Offering screening for neurodivergence to people detained by the police could help ensure access to appropriate support and ...

International Day of People with Disability scholar Mark du Potiers shares how attention deficit hyperactivity disorder ...

A scoping review maps barriers and enablers in the transition to adult mental health services for autistic and ADHD youth, ...

A popular TikTok doctor, Dr. Ali Ajaz, shared 12 questions to help identify potential adult ADHD symptoms. These questions ...

Offering screening for neurodivergence to people detained by the police could help ensure access to appropriate support and fairer treatment in the criminal justice system, say Cambridge researchers, ...

Foresight Psychology, based in San Diego, CA, but serving most of the US, is introducing specialized ADHD testing services ...